AstraZeneca recently partnered with Accent Therapeutics to discover, develop, and commercialize novel cancer therapeutics targeting RNA-modifying proteins (RMPs).
The companies will focus on targeting...
The climbing death toll of the coronavirus is pushing the pharmaceutical industry to respond quickly, and for many, only a vaccine or effective treatment options will help them return the world back to some semblance of normalcy.
For more...
An antibody isolated from a patient who recovered from severe acute respiratory syndrome (SARS) in 2003 could be a potential therapeutic COVID-19 antibody, according to a study recently published in...
Moderna recently received $483 million from the Biomedical Advanced Research and Development Authority (BARDA) to bolster COVID-19 vaccine development using the company’s mRNA vaccine...
The Pfizer Foundation recently announced the commitment of $40 million in medical and charitable cash grants to help combat the global health effects of the COVID-19 pandemic.
For more...
Slightly over a third of cancer patients are eligible for immune checkpoint inhibitor (ICI) drugs but even fewer are responding to the innovative treatment, according to researchers from Oklahoma State...
ICER adopts Aetion’s platform to advance standards for how real-world evidence can inform decision making for clinical trials and enhance overall patient care.
The Institute for Clinical...
The National Institute of Health (NIH) is sponsoring the first controlled clinical trial in the US at the University of Nebraska Medical Center (UNMC) to evaluate a possible coronavirus (COVID-19)...
A broad coalition is calling for Congress to ensure Medicaid patients receive access to potentially life-saving clinical trials, according to a recent letter to Congressional leaders.
Last week, 106...
Janssen Pharmaceutical Companies will expand its partnership with Department of Health and Human Services (HHS) to accelerate a vaccination discovery for the coronavirus or COVID-19, Johnson &...
Michigan Medicine’s C.S. Mott Children’s Hospital recently announced that it has joined the top children’s hospitals from the United States, Canada, Australia, and Europe to...
With industry’s growing use of real-world evidence in drug development and discovery, the Food and Drug Administration is looking to encourage further use of real-world data by having its...
Nearly a year to the day after acquiring a portion of HIMSS Analytics, data analytics and business intelligence company Definitive Healthcare has announced the acquisition of software analytics firm...
A new study finds that leveraging physician ties can promote targeted adoption of high-value therapies.
As part of the longitudinal study published in JAMA, researchers constructed physician networks...
The US Senate has voted to confirm Stephen Hahn, MD, the former chief medical executive for MD Anderson Cancer Center in Texas, as the new commissioner for the Food and Drug Administration (FDA).
In a...
